Today, Paxman publishes the June issue of its newsletter aimed at shareholders, investors and other interested parties.

This month’s issue highlights that Paxman has signed distribution agreements with PT. Gekha Karunia Abad for Indonesia and VisionTech International for Bangladesh. With the agreement for Singapore, Paxman will establish its business in the world’s fourth most populous country. Singapore has a population of 270 million people, a well-established public health insurance system covering 80 percent of the country’s population, and an ambitious National Cancer Control Program to facilitate early detection and treatment of cancer. Bangladesh is one of the most densely populated countries in the world, with a population of over 164 million.

The newsletter also includes information on recruitments to Paxman’s quality team in the UK and international positions in France, Germany, India and Scandinavia, and that this month’s orders and installations include 5 systems to Southend Hospital in the UK, 4 to the Netherlands and 3 to Brazil, as well as orders to cancer centers in New Hampshire, Florida, Minnesota, Texas and Tennessee in the United States.

To read the newsletter and subscribe for upcoming issues, follow this link:

http://bit.ly/paxjun21en

PAXMAN’s investor newsletter is published monthly as a part of the company’s effort to strengthen its market communication together with the IR communication agency Honeybadger. Every published issue of the newsletter is available on PAXMANs website for investors, www.paxman.se. The company encourages feedback and requests on topics for upcoming issues of the newsletter.

Contacts

Richard Paxman, CEO
Tel: +44 7968 020641
Email: richard@paxmanscalpcooling.com
www.paxman.se

About Us

The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. With close to 3,500 systems delivered in to hospitals, clinics and treatment centres around the world, PAXMAN is the leading supplier of Scalp Cooling technology. PAXMAN’s scalp-cooling cap is made from lightweight, biocompatible silicone that is soft and flexible, providing a snug yet comfortable fit during treatment. PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden), with subsidiaries in Huddersfield (UK) and Houston, Texas (US).

The PAXMAN share is listed on Nasdaq First North Growth Market. FNCA Sweden AB is the company’s Certified Adviser and can be contacted via info@fnca.se and +46 (0)8 528 003 99.

Attachments

Paxman publishes newsletter on new distribution partners in Indonesia and Bangladesh

© Modular Finance, source Nordic Press Releases